|
Delayed
OTC Markets
|
5-day change | 1st Jan Change | ||
| - USD | -.--% |
|
-4.49% | -0.54% |
| 29/03/22 | Novelion Therapeutics Inc. Announces Final Cash Distribution, Payable on or About March 31, 2022 | CI |
| 17/01/20 | Novelion Therapeutics Inc. Announces Management Changes | CI |
| Market Cap | 13.85M 12M 11.34M 10.3M 19.3M 1.33B 19.41M 135M 52.32M 674M 52.02M 50.86M 2.15B | P/E 2017 |
-0.46x | P/E 2018 | -0.15x |
|---|---|---|---|---|---|
| Enterprise Value | 317M 275M 260M 236M 442M 30.43B 445M 3.1B 1.2B 15.43B 1.19B 1.17B 49.19B | EV / Sales 2017 |
1,887,512x | EV / Sales 2018 | 2,447,567x |
| Free-Float |
-
| Yield 2017 * |
-
| Yield 2018 | - |
| Date | Insider | Type | Main position | Quantity | % Market Cap. | Importance |
|---|---|---|---|---|---|---|
| 4/9/20 A | Edgepoint Investment Group, Inc.
| Buy | Company | 1,317 | 0.0067% | |
| 4/9/20 A | Edgepoint Investment Group, Inc.
| Other | Company | 0 | 0% | - |
| 4/9/20 A | Edgepoint Investment Group, Inc.
| Sell | Company | 750,000 | 3.8228% |
| 2017 | 2018 | |
|---|---|---|
| Net sales | 138.44 119.97 113.39 102.94 192.94 13.28K 194.09 1.35K 523.07 6.74K 520.04 508.5 21.47K | 130.43 113.03 106.83 96.99 181.78 12.51K 182.87 1.28K 492.82 6.35K 489.97 479.09 20.23K |
| Net income | -127M -110M -104M -94.22M -177M -12.16B -178M -1.24B -479M -6.17B -476M -465M -19.65B | -108M -93.88M -88.73M -80.55M -151M -10.39B -152M -1.06B -409M -5.27B -407M -398M -16.8B |
| Net Debt | 203M 176M 166M 151M 283M 19.48B 285M 1.99B 767M 9.88B 763M 746M 31.5B | 303M 263M 248M 226M 423M 29.1B 425M 2.97B 1.15B 14.76B 1.14B 1.11B 47.05B |
Employees
-
Sector
-
- Stock Market
- Stocks
- NVLNF Stock
Select your edition
All financial news and data tailored to specific country editions
